Private Equity 3 Days

Last updated: May 17, 2026, 5:30 PM ET

Physical-World Investing and Defense Tech Surge

The private equity world continues to tilt toward companies that build in the physical world, with several billion-dollar deals clustering around chips, drones, and defense infrastructure this week. Eclipse's $2.5 billion investment in Cerebras Systems marks a pivotal bet on the AI chipmaker that almost died early on, burning $8 million a month while developing a wafer-scale chip many engineers considered impossible. The Cerebras IPO is shaping up as the year's biggest tech listing, giving Eclipse's Lior Susan a tangible payoff for a thesis he has championed since the firm's inception. On the defense side, Anduril Industries led the week's fundraising roundup with a $5 billion financing, reinforcing a broader appetite for physical-world tech that extends well beyond Silicon Valley laptops. A Dutch dronemaker Destinus is reportedly in €200 million funding talks, and Crunchbase flagged multiple startup deals focused on problems in the physical world — from cell-based milk to defense tech built near battlefields. The pattern suggests LPs are increasingly willing to fund capital-intensive, tangible assets over software-only plays.

New Fund Formation and Early-Stage Venture Activity

Several new funds and rounds underscore a willingness to back founders outside the traditional venture playbook. Meridian Ventures launched a $35 million fund targeting MBA-deferred founders building enterprise technology, while AI-powered marketing platform Nectar Social raised a $30 million Series A led by Menlo Ventures and its Anthropic-linked Anthology Fund. Euan Blair's Multiverse boosted its valuation with a $70 million fundraise, and an 11-person London startup is chasing a goal of making AI 100 times cheaper every year. Across the Atlantic, European startups are actively raising capital and hunting for acquisitions, signaling that the fundraising cycle remains healthy even as valuations face renewed scrutiny. These moves come as tech founders and investors dominate the Sunday Times Rich List for 2026, placing founders center stage in a wealth creation narrative that private equity has long aspired to replicate through portfolio companies.

Major M&A and Control Deals

Private equity deal-making picked up across healthcare, industrials, and consumer staples. Blackstone and KKR are seizing control of Affordable Care through a restructuring that will write off roughly 70 percent of the company's debt, a sharp downcycle move that could reshape the home health payer's capital structure. In healthcare services, Kinderhook completed a take-private acquisition of Enhabit Home Health & Hospice, and Charlesbank-backed Tecomet merged with Nordic-backed Orchid Orthopedic Solutions to create a combined orthopedic device platform operating under the Tecomet name. On the industrials front, Fusion Capital-backed Relevant acquired systems integration firm Automation Werx, while HIG Capital snapped up International Aerospace Coatings, a supplier serving major airlines and MRO providers. Consumer staples saw movement too: Blackstone and CD&R are evaluating take-private bids for Magnum Ice Cream Company, which trades below its IPO price. Meanwhile, CPP Investments committed €400 million to co-invest alongside Blackstone in French last-mile logistics platform Proudreed, a deal that pairs European sovereign-wealth capital with U.S. buyout muscle.

Pharma, Testing, and Sector Rotation

Private equity is pushing deeper into pharma services and testing as investors hunt for revenue predictability. Blackstone, Audax, and Five Arrows are eyeing pharmaceutical and life science consulting firms, driven by growing complexity in drug R&D that makes data analytics and consulting platforms attractive bolt-on targets. Eir Partners invested in QuartzBio, a life sciences data analytics company, reflecting the same thesis. Separately, Ardian, Blackstone, Bridgepoint, and EQT are among firms tapping into the testing and inspection sector, drawn by the TICC industry's stable, recurring revenue streams. TICC's embrace of AI is helping attract private equity interest, according to Houlihan Lokey, which argues that the firm's willingness to adopt AI tools enhances its appeal as a portfolio asset.

Industry Dynamics and Conference Circuit

The private equity calendar is filling up with marquee events that signal continued institutional momentum. Italy's largest private equity conference returns to Milan next May, France's largest returns to Paris next March, and the Nordics' largest will convene in Stockholm this November, offering sponsors and LPs a slate of networking opportunities across Europe's key markets. At the same time, General Catalyst posted what analysts called VC rage bait on social media, and it worked — prompting repeated responses from a16z's Marc Andreessen, a reminder that public spats between firms remain a potent driver of deal flow conversation. On the wealth-access front, industry observers are making the case for opening private equity to private wealth, citing longer private-company lifespans and growing retail allocations, a structural shift that could deepen the pool of capital chasing the same deals.